The Synergistic Effects of Astragalus Mongholicus and Salvia Miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment [Retraction]

Zhang Y, Wang J, Liu YM, Chen YY, Yang XC, Duan L. Drug Des Devel Ther. 2021;15:4053–4069. We, the Editors and Publisher of the journal, Drug Design, Development and Therapy have retracted the published article. After publication, concerns have been raised by a third party about the integrity of the data in Figure 7 of the article. Further investigations conducted by the Journal and Publisher confirmed duplicate image panels representative of different treatment conditions present in Figure 7. When approached for an explanation, the authors have provided their raw data and the relevant documentation. However, further data integrity concerns have been identified in the raw data provided. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed. We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2025-10-03
Primary Topic
Traditional Chinese Medicine Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Synergistic Effects of Astragalus Mongholicus and Salvia Miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment [Retraction]

Dove Medical Press (Taylor and Francis Group)
Traditional Chinese Medicine Analysis
article

The Synergistic Effects of Astragalus Mongholicus and Salvia Miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment [Retraction]

article en

Abstract

Zhang Y, Wang J, Liu YM, Chen YY, Yang XC, Duan L. Drug Des Devel Ther. 2021;15:4053–4069. We, the Editors and Publisher of the journal, Drug Design, Development and Therapy have retracted the published article. After publication, concerns have been raised by a third party about the integrity of the data in Figure 7 of the article. Further investigations conducted by the Journal and Publisher confirmed duplicate image panels representative of different treatment conditions present in Figure 7. When approached for an explanation, the authors have provided their raw data and the relevant documentation. However, further data integrity concerns have been identified in the raw data provided. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed. We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

Dove Medical Press (Taylor and Francis Group)
Openalex Percentile: Top 27%
Traditional Chinese Medicine Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.